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Background Transcatheter aortic valve implantation (TAVI) is the procedure of choice for aortic stenosis in high surgical risk patients,
but it is no free from complications.
...............................................................................................................................................................................................................
Case summary A 86-year-old patient with severe aortic stenosis underwent TAVI 3 years ago with an Edwards Sapiens valve by femoral
access. In the echocardiography follow-up, an aorta–right ventricular (Ao-RV) fistula was noted with restrictive flow and
no significant shunt and it was treated conservatively. Three years after TAVI, the patient underwent cardiac surgery be-
cause of worsening heart failure due to a severe degenerative mitral regurgitation with tethering of P2 due to left ven-
tricular remodelling, a posterior jet of severe regurgitation, and left ventricular dilatation. Surgical replacement of the
TAVI and aortic root with a bioprosthesis (Medtronic Freestyle) and direct closure of the fistula was performed along
with the mitral valve replacement. The patient was discharged with a good clinical result and no evidence of remaining
Ao-RV fistula at transthoracic echocardiography.
...............................................................................................................................................................................................................
Discussion Aorta–right ventricular fistula is a rare entity. Most reported cases arise after rupture of a congenital coronary sinus an-
eurism, endocarditis, trauma, and aortic valve or aortic root surgery. This is the 10th reported case after TAVI (9 after an
Edwards Sapiens TAVI). Non-significant shunt can be treated conservatively but development of heart failure and death
are described in significant shunts. Balloon post-dilatation and the absence of surgical calcium debridement inherent to
TAVI may theoretically contribute to the development of the fistula. Surgical replacement and closure of the fistula is a
therapeutic option for this entity even in high-risk patients.
                                                                                                                                                                                                                   
Keywords Transcatheter aortic valve implantation (TAVI) • Aortocardiac fistula • Aortic valve replacement • Aorto–right ven-
tricular fistula • Case report
*Corresponding author. Tel: þ41 795337126, Email: mario.verdugo-marchese@chuv.ch
Handling Editor: De Carlo Marco
Peer-reviewers: Thomas Schachner, Marcelo Haertel Miglioranza, and Riccardo Liga
Compliance Editor: Carlos Minguito Carazo
Supplementary Material Editor: Peregrine Green
VC The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com









































Transcatheter aortic valve implantation (TAVI) is the procedure of
choice for aortic stenosis patients with high surgical risk and can be
considered in intermediate and low-risk patients with favourable
anatomy. While the procedure is less invasive than standard surgical
valve replacement, it is not free from complications. In the follow-up
of patients with aortic valve stenosis who were considered poor sur-
gical candidates, incidental disease may pose again the indication for
cardiac surgery.
The absence of debridement of the diseased calcified native aortic
valve, which is inherent of the TAVI technique, has been related to
paravalvular leaks, atrioventricular block, and vascular complications
(including aortic root haematoma and rupture).1–3
We expose the case of a patient who developed an aorta–right
ventricular (Ao-RV) fistula shortly after transfemoral TAVI, initially
conservatively followed, which developed degenerative mitral valve
regurgitation and required subsequent cardiac surgery for mitral and
coronary artery disease at the age of 86 years.
Timeline
Case presentation
An 86-year-old man with an history of degenerative aortic stenosis
(Supplementary material online, Video S1) and treated by TAVI
(Edwards Sapiens 3, 29 mm) 3 years ago, coronary artery disease
(pre-TAVI coronary angiography with a 50–70% bifurcation lesion of
the anterior descending involving the first diagonal branch), a per-
manent bicameral pacemaker implanted 6 months ago because sick
sinus syndrome and arterial hypertension. In the month following the
TAVI procedure, an Ao-RV fistula was noticed during a routine trans-
thoracic echocardiography with a restrictive, non-significant shunt
(Supplementary material online, Videos S2 and S3). No specific treat-
ment was required and a standard pharmacological treatment with
conventional clinical and echocardiography follow-up was
programmed.
During the last year, the patient had worsening heart failure symp-
toms (progressive oedema of the lower limbs, New York Heart
Association dyspnoea class III, and acute pulmonary oedema epi-
sodes) which prompted multiple hospitalizations. A new severe mi-
tral insufficiency was diagnosed at echocardiography follow-up by his
cardiologist. After case review by our hospital heart team, a surgical
mitral valve replacement was decided despite the complexity of the
case and high perioperative risk (EUROSCORE II 28.18%, Clinical
frailty scale 4/7 ‘Vulnerable’) due to the lack of other therapeutic
options offering a complete treatment. He was admitted for elective
surgery and patient consent was obtained before the procedure for
the academic use of his clinical data. At admission, the patient had a
regular cardiac rhythm a 70 b.p.m., with a pansystolic 3/6 mitral regur-
gitation murmur, basal bilateral pulmonary rales, a discrete lower
limb oedema, and a blood pressure of 125/56 mmHg.
The preoperative transthoracic echocardiography confirmed a de-
generative and calcified mitral valve with a posterior jet of severe re-
gurgitation of mixed aetiology mainly due to tethering of P2
Figure 1 (A) Transthoracic colour Doppler echocardiography,
short-axis view of the aorta–right ventricular fistula in telediastole
(arrow). (B) Pre-transcatheter aortic valve implantation computed
tomography scan (in the same orientation of the main image) show-
ing calcifications in the base of the right coronary leaflet of the sten-
otic aortic valve.
Learning points
• Complex patients should not be excluded from cardiac surgery only based on risk if a significant clinical benefit is expected and no less inva-
sive comparable options are available.
• Aorto–right ventricular fistula is a rare complication of transcatheter aortic valve implantation.
• Non-significant shunt may be treated conservatively but important morbidity and mortality have been described in severe shunts.
.................................................................................................
3 years prior to surgery Severe aortic stenosisTAVI (Edwards
Sapiens valve)
Aorto–right ventricular (Ao-RV) fistula
noted on echocardiography at follow-up
1 year prior to surgery Heart failure—severe mitral regurgitation
Surgery Surgical mitral and aortic valve replacement
with closure of the Ao-RV fistula
2 weeks after surgery Patient discharge
















































..secondary to left ventricular remodelling (Carpentier classification
IIIb; Supplementary material online, Video S4), a dilated left ventricle
(telediastolic volume index of 97 mL/m2) with an ejection fraction of
46%, anterior wall hypokinesia (Supplementary material online, Video
S5), a dilated left atrium (55 mL/m2), and a systolic pulmonary artery
pressure estimated at 45 mmHg. The TAVI valve had a mean gradient
of 6 mmHg and a surface of 2.2 cm2. An image consistent with an Ao-
RV fistula, with restrictive continuous flow (Vmax 4.2 m/s) was noticed
between the anterior aspect of the aortic valvular annulus, immedi-
ately distal to the valvular plan of the aortic prosthesis, and the right
ventricular side of the interventricular septum, adjacent to crista
supraventricularis with an anterior directed jet, this was coincident
with annular calcifications in the base of the right coronary leaflet of
the aortic valve, prior to TAVI (Figure 1, Supplementary material on-
line, Videos S6 and S7). A preoperative coronary angiography con-
firmed a severe stenosis (70–90%) of the proximal left anterior
descending coronary artery (LAD) prompting the indication for cor-
onary bypass. The mitral valve anatomy was considered not suitable
for percutaneous edge to edge mitral valve repair because of severe
annular calcification. The echocardiographic findings were confirmed
by the intraoperative transoesophageal echocardiography
(Supplementary material online, Videos S8 and S9) and direct surgical
exploration of the diseased valve.
The patient underwent cardiac surgery under standard cardiopul-
monary bypass (total time 156 min; aortic cross-clamp 138 min) with
explantation of the TAVI (to better expose the mitral valve for re-
placement and the Ao-RV fistula for closure), surgical replacement of
the mitral valve with a porcine stented bioprosthetic valve (St Jude
Epic, size 31), coronary bypass (left internal thoracic artery to LAD),
direct closure of the Ao-RV fistula (Figure 2), and total aortic root re-
placement using a porcine stentless bioprosthetic valved aortic root
(Medtronic Freestyle, size 27) because of anatomic alteration of the
aortic root after TAVI explantation.
The patient had a standard post-operative recuperation and was
transferred to a cardiac rehabilitation facility 2 weeks after surgery.
Post-operative echocardiography confirmed the absence of Ao-RV
and the normal function of both implanted valves (Supplementary
material online, Video S10). The patient was followed in our out-
patient clinic and is still doing well 2 months after the procedure.
Figure 2 Surgical view of the aorta–right ventricular fistula (white
arrow) after transcatheter aortic valve implantation and aortic root
explantation, with the plastic aspiration probe (white *) passing
through the fistula.
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Table 1 Reported cases
Author Age/sex TAVI type Diagnostic
delay
Qp/Qs Symptoms Treatment Outcome






3 days 1.53 No No Asymptomatic at 1 year
Shakoor 2015 89/male Edwards Sapien 1 day 1.39 Worsening HF Conservative Died at follow-up
Leroux 2016 47/male Edwards Sapien 3 weeks NA Dyspnoea Medical Died, Sudden at 4 months
Leu 2016 78/female Edwards Sapien 2 weeks 1.13 No No Asymptomatic at 4 years
Almanfi 2017 92/male Edwards Sapien XT 1 day NA No No Asymptomatic at 1 year
Nakamura 2017 54/male Edwards Sapien XT 5 days 1.7 Cardiogenic shock Septal Occluder Discharged asymptomatic
Hagiwara 2017 83/male Edwards Sapien XT 7 days 1 Mild haemolytic
anaemia
Medical Asymptomatic at 9 months
Konda 2017 88/female Edwards Sapien XT 4 days 2 Worsening HF after
3 months
Conservative Died at 9 months






Patients from refs5–13 and current case.
HF, heart failure; NA, non-available; RV, right ventricular.
aSurgical indication was related to the severe mitral regurgitation.






This complex case highlights that cardiac surgery should not be
excluded based only in the operative risk if no other therapeutic
options are available and a significant clinical benefit is expected.
Perioperative risk scores, such as EUROSCORE II, tend to overesti-
mate mortality in high-risk patients4 and including frailty evaluation
may improve outcome prediction.5 A tailored approach should pre-
vent to inaccurately deny surgery to elderly patients.
Aorta–right ventricular fistula is a rare entity. Most cases reported
are due to a rupture of a congenital coronary sinus aneurysm. Other
aetiologies include endocarditis, trauma, and iatrogenic Ao-RV fis-
tula.6 The latter is described after cardiac surgery in aortic valve or
aortic root replacement and after TAVI.
Aorta–right ventricular fistula is an extremely infrequent complica-
tion after TAVI, being a subtype of aortic annular rupture. With more
than 400 000 TAVI performed worldwide since the beginning of the
technique this is only the 10th reported case in the literature (Table
1).7–15 Including our case, nine of the 10 reported cases developed
the fistula after implantation of an Edwards Sapiens TAVI, probably
related to balloon dilatation in a non-decalcified aortic valve during
the implantation procedure. The last case had a post-dilatation pro-
cedure after Medtronic CoreValve TAVI implantation.11
All of the reported cases were of late-onset (24 h to 1 month),
which suggests that the fistula is a secondary complication, probably
after aortic annulus haematoma.
Three patients died at follow-up (two from heart failure and one
from sudden cardiac death, respectively). Of the surviving patients
reported, four where not treated (reported Qp/Qs ranging from 1
to 1.53), one patient had the fistula closed with an atrial septal
occluder and one with coil embolization.
Our patient is the first reported case treated surgically, but his sur-
gical indication was related to the severe mitral regurgitation and not
directly related to the Ao-RV fistula. Despite the fact that the Ao-RV
fistula was not haemodynamically significant in our patient, its closure
was feasible without a great increase in the surgical complexity of the
case, avoiding the possible progression to a significant fistula with diffi-
cult therapeutic options. Along with the balloon post-dilatation, the
absence of calcium debridement may contribute to the formation of
the fistula.
Conclusion
Complex cardiac surgery should be proposed to patients who
might benefit despite the operative risk if no therapeutic options
are available and a net clinical benefit is expected. Despite the
rarity of Ao-RV fistula after TAVI it must be considered, especially
in the echocardiography follow-up of the patients. Surgical re-
placement of the prosthesis and closure of the fistula is a thera-
peutic option for this entity. In highly calcified aortic valves, the
benefits of surgical debridement must be considered in the thera-
peutic decision-making.
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